序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
1 | 1454902-97-6 | Elevenostat |
≥98% | | 询价 |
2 | 1205538-83-5 | Calpinactam |
≥98% | | 询价 |
3 | 2751721-40-9 | AZ5576 |
≥98% | | 询价 |
4 | 2499491-04-0 | STAT3-IN-10 |
≥98% | | 询价 |
5 | 1026785-59-0 | cis-Lomibuvir |
≥98% | | 询价 |
6 | 126775-74-4 | Himastatin |
≥98% | | 询价 |
7 | 2452118-54-4 | VIM-2-IN-1 |
≥98% | | 询价 |
8 | 265989-49-9 | 4-Hydroxy Atorvastatin lactone-d5 |
≥98% | | 询价 |
9 | 265989-45-5 | 4-Hydroxy Atorvastatin-d5 calcium |
≥98% | | 询价 |
10 | 2130853-04-0 | Belinostat acid-d5 |
≥98% | | 询价 |
11 | 2043026-13-5 | Roxadustat-d5 |
≥98% | | 询价 |
12 | 1285539-74-3 | Febuxostat-d7 |
≥98% | | 询价 |
13 | 1185237-51-7 | Panobinostat-d4 HCl |
≥98% | | 询价 |
14 | 265989-50-2 | Ortho-hydroxy atorvastatin lactone-d5 |
≥98% | | 询价 |
15 | 2712343-38-7 | Raltegravir-d4 |
≥98% | | 询价 |
16 | 1801709-41-0 | Daclatasvir-d6 |
≥98% | | 询价 |
17 | | Givinostat impurity 1-d10 HCl |
≥98% | | 询价 |
18 | 1356934-56-9 | Ertapenem-d4 disodium |
≥98% | | 询价 |
19 | | Pravastatin-13C,d3 sodium |
≥98% | | 询价 |
20 | | LQVTDSGLYRCVIYHPP TFA |
≥98% | | 询价 |
21 | | RAR ligand 1(Ch55-O-C3-carbaldehyde) |
≥98% | 50mg, 100mg, 250mg | 询价 |
22 | | PROTAC IAP binding moiety 2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
23 | | PROTAC IAP binding moiety 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
24 | | PROTAC BRD9-binding moiety 1 hydrochloride |
≥98% | 50mg, 100mg, 250mg | 询价 |
25 | | E3 ligase Ligand-Linker Conjugates 32 hydrochloride |
≥98% | 50mg, 100mg, 250mg | 询价 |
26 | | E3 ligase Ligand 1 dihydrochloride |
≥98% | 50mg, 100mg, 250mg | 询价 |
27 | | E3 ligase Ligand 13 |
≥98% | 50mg, 100mg, 250mg | 询价 |
28 | | CDK9 Antagonist-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
29 | | PROTAC B-Raf degrader 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
30 | | PROTAC CRBN Degrader-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
31 | | PROTAC FAK degrader 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
32 | | PROTAC ER Degrader-2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
33 | | PROTAC ERαDegrader-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
34 | | TD-428 |
≥98% | 50mg, 100mg, 250mg | 询价 |
35 | | E3 Ligase Ligand-Linker Conjugates 23 TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
36 | | E3 ligase Ligand-Linker Conjugates 15 |
≥98% | 50mg, 100mg, 250mg | 询价 |
37 | | E3 ligase Ligand-Linker Conjugates 35 Hydrochlride |
≥98% | 50mg, 100mg, 250mg | 询价 |
38 | | E3 ligase Ligand-Linker Conjugates 42 |
≥98% | 50mg, 100mg, 250mg | 询价 |
39 | | E3 ligase Ligand-Linker Conjugates 44 |
≥98% | 50mg, 100mg, 250mg | 询价 |
40 | | E3 ligase Ligand-Linker Conjugates 46 |
≥98% | 50mg, 100mg, 250mg | 询价 |
41 | | E3 ligase Ligand-Linker Conjugates 33 |
≥98% | 50mg, 100mg, 250mg | 询价 |
42 | | E3 ligase Ligand-Linker Conjugates 45 |
≥98% | 50mg, 100mg, 250mg | 询价 |
43 | | E3 ligase Ligand-Linker Conjugates 30 TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
44 | 1125758-85-1 | A-804598(A804598) |
≥98% | | 询价 |
45 | 87304-15-2 | E3 ligase Ligand 9 |
≥98% | 50mg, 100mg, 250mg | 询价 |
46 | 2369022-68-2 | PROTAC PARP1 degrader |
≥98% | | 询价 |
47 | 2341740-84-7 | BI-3663 |
≥98% | | 询价 |
48 | 201009-98-5 | H-Lys(Fmoc)-OMeoHCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
49 | 148515-85-9 | Fmoc-(Fmoc-Hmb)-Ala-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
50 | 159610-89-6 | Fmoc-Lys(N3)-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
51 | 775-06-4 | DL-m-Tyrosine |
≥98% | 50mg, 100mg, 250mg | 询价 |
52 | 93267-04-0 | Boc-Ala(I)-Ome |
≥98% | 50mg, 100mg, 250mg | 询价 |
53 | 17664-93-6 | H-D-Leu-OBzl,Tos,OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
54 | 7517-19-3 | H-Leu-Ome,HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
55 | 328-38-1 | H-D-Leu-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
56 | 5978-22-3 | H-Lys(Z)-OtBu,HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
57 | 23500-04-1 | Ac-Lys(Boc)-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
58 | 148101-51-3 | Ac-Lys(Fmoc)-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
59 | 2389-48-2 | H-Lys(Boc)-Ome,HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
60 | 69630-50-8 | H-D-Asp(OMe)-OMe,HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |